Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

52.33USD
24 May 2019
Change (% chg)

$1.38 (+2.71%)
Prev Close
$50.95
Open
$51.37
Day's High
$52.43
Day's Low
$50.96
Volume
72,620
Avg. Vol
200,459
52-wk High
$60.98
52-wk Low
$35.86

About

Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $1,444.21
Shares Outstanding(Mil.): 25.69
Dividend: --
Yield (%): --

Financials

  ESPR.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -5.77 -- --
ROI: -61.42 8.91 13.82
ROE: -61.71 10.05 15.25

Earnings vs. Estimates